Advances in molecular pathogenesis and clinical therapy of multiple myeloma: a 2013 EHA annual meeting press releases
10.3760/cma.j.issn.1009-9921.2013.08.002
- VernacularTitle:骨髓瘤发病与诊治进展:2013年欧洲血液学会年会报道
- Author:
Juan DU
;
Jian HOU
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Intraclonal heterogeneity;
Novel therapeutic agents;
Relapse;
Refractory;
EHA annual meeting
- From:
Journal of Leukemia & Lymphoma
2013;22(8):451-452
- CountryChina
- Language:Chinese
-
Abstract:
Multiple myeloma (MM) is a genetically complex disease that is becoming more common in today' s aging population.In the 18th European Hematology Association (EHA) annual meeting,there were a number of key topics focusing on the development of MM from intraclonal heterogeneity,novel therapeutic agents,and relapse and refractory MM therapy,etc.
